Okinawa Pharmaceuticals Private Limited, a active private limited company, was established on 30 December 2015 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101MH2015PTC306595. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 32 professional, Its leadership includes Srujana Bitra (Additional Director), Anjaneyulu Boddapati (Additional Director), Venkatrao Mandati (Additional Director). Past directors included Nagajyothi Chandrapati, Naga Venkata Jakka Sita Kusuma Deepthi, Rajasekhar Reddy Yeruva. It holds ₹3.40 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No.611, 6Th Floor, Reliables Pride,Anand Nagar,Jogeshwari W, Est, Mumbai, Maharashtra, 400102.
U51101MH2015PTC306595
306595
30 December 2015
₹5.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Okinawa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srujana Bitra | Additional Director | 06 Apr 2024 | Current |
| Anjaneyulu Boddapati | Additional Director | 06 Apr 2024 | Current |
| Venkatrao Mandati | Additional Director | 04 Apr 2024 | Current |
| Chandra Sekhara Reddy Eduru | Director | 26 Dec 2017 | Current |
| Divyakolu Ramanjaneyulu | Additional Director | 04 Apr 2024 | Current |
| Ramadevi Ananthu | Director | 30 Dec 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Oct 2017 | Past |
| Pramod Abcsdd | Director | 23 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Okinawa Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.64% increase. The company also saw a slight decrease in profitability, with a 6.78% decrease in profit. The company's net worth Soared by an impressive increase of 142.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Okinawa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,400,769.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 2021 | Hdfc Bank Limited | ₹3.40 M | Open |
Explore comprehensive loan charge details -
Okinawa Pharmaceuticals has a workforce of 32 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Okinawa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okinawa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Okinawa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Srujana Bitra was appointed as a Additional Director was appointed as a Additional Director on 06 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
The activity Anjaneyulu Boddapati was appointed as a Additional Director was appointed as a Additional Director on 06 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
Progress on Venkatrao Mandati was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
Progress on Divyakolu Ramanjaneyulu was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
The activity Okinawa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The CIN of Okinawa Pharmaceuticals Private Limited is U51101MH2015PTC306595.
Okinawa Pharmaceuticals Private Limited is headquartered at Unit No.611, 6Th Floor, Reliables Pride,Anand Nagar,Jogeshwari W, Est, Mumbai, Maharashtra, 400102.
Okinawa Pharmaceuticals Private Limited was incorporated on 30 December 2015.
The current directors of Okinawa Pharmaceuticals Private Limited are
The primary industry of Okinawa Pharmaceuticals Private Limited is Trade.
Okinawa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Okinawa Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Okinawa Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX